Probiotics in Transition

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 11, 2012, Pages 1220-1224

  Shanahan, Fergus ^a   Dinan, Timothy G ^a   Ross, Paul ^a   Hill, Colin ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Bifidobacterium; Lactobacillus; Microbiota

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIUM LONGUM INFANTIS; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; GASTROENTEROLOGY; MICROBIAL COLONIZATION; MICROBIAL DIVERSITY; MICROFLORA; MOLECULAR MIMICRY; SIGNAL TRANSDUCTION; SUPPLEMENTATION;

BIFIDOBACTERIUM; GASTROINTESTINAL DISEASES; HUMANS; LACTOBACILLUS; MODELS, BIOLOGICAL; PROBIOTICS;

EID: 84867662206     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.09.020     Document Type: Article

References (26)

1. The Economist. Leader. Microbes maketh man Accessed August 2012. http://www.economist.com/node/21560559.
2. Shanahan F. The gut microbiota: a clinical perspective on lessons learned. Nat Rev Gastroenterol Hepatol 2012, Aug 14 [Epub ahead of print].
3. Clemente J.C., Ursell L.K., Parfrey L.W., et al. The impact of the gut microbiota on human health: an integrative view. Cell 2012, 148:1258-1270.
4. Cho I., Blaser M.J. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012, 13:260-270.
5. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria 2001 FAO/WHO, Accessed June 4, 2012. http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
6. Shanahan F. Probiotics in perspective. Gastroenterology 2010, 139:1808-1812.
7. Claesson M.J., Jeffery I.B., Conde S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-184.
8. Shanahan F. Molecular mechanism of probiotic action: it's all in the strains!. Gut 2011, 60:1026-1027.
9. Grenham S., Clarke G., Cryan J.F., et al. Brain-gut-microbe communication in health and disease. Front Physiology 2011, 2:94.
10. Sonnenburg J.L., Chen C.T., Gordon J.I. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 2006, 4:e413.
11. Marchesi J.R. Human distal gut microbiome. Environ Microbiol 2011, 13:3088-3102.
12. Corr S.C., Li Y., Riedel C.U., et al. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A 2007, 104:7617-7621.
13. O'Mahony C., Scully P., O'Mahony D., et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-κB activation. PLoS Pathogens 2008, 4. e1000112.
14. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 2010, 8:171-184.
15. Van Baarlen P., Troost F., van der Meer C., et al. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4562-4569.
16. Fernandez E.M., Valenti V., Rocke C., et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 2011, 60:1050-1059.
17. O'Connell Motherway M., Zomer A., Leahy S.C., et al. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci U S A 2011, 108:11217-11222.
18. Fanning S., Hall L.J., Cronin M., et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 2012, 109:2108-2113.
19. O'Mahony L., McCarthy J., Kelly P., et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541-551.
20. Preidis G.A., Hill C., Guerrant R.L., et al. Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 2011, 140:8-14.
21. Hempel S., Newberry S.J., Maher A.R., et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012, 307:1959-1969.
22. Whorwell P.J., Altringer L., Morel J., et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006, 101:1581-1590.
23. Shanahan F. The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain. Nutr Rev 2012, 70(Suppl 1):S31-S37.
24. Naidoo K., Gordon M., Fagbemi A.O., et al. Probiotics for maintenance of remission of ulcerative colitis. Cochrane Database Syst Rev 2011, 12. CD007443.
25. Gionchetti P., Rizzello F., Venturi A., et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:305-309.
26. Mimura T., Rizzello F., Helwig U., et al. Once-daily high-dose probiotic therapy (VSL# 3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004, 53:108-114.